Most employers receive pharmacy benefit performance reports from their PBM, but few have an independent way to determine whether their results are truly competitive relative to similar companies.
Join Chief Strategy Officer Kian Bichoupan, PhD, for an educational webinar that walks through Truveris’ latest approach to benchmarking pharmacy financial performance, including key metrics that strongly influence overall plan health. Using real-world examples, we’ll show you how to interpret these metrics and what to look for when evaluating your next PBM contract.
Attendees will gain practical insights into common pharmacy benefit metrics, learn where plans may underperform without realizing it, and discover how benchmarking can help identify areas for further contract review and improvement.
Whether you’re preparing for a renewal or looking to better understand the financial drivers behind your pharmacy spend, this session will provide a useful framework for assessing your plan with greater confidence.
Learning Objectives
- Learn how benchmarking your contract provides valuable market context – See how comparing pharmacy benefit performance against similar plans can help identify strengths, uncover potential inefficiencies, and highlight areas worth investigating further.
- Understand the pharmacy benefit metrics that matter most – Learn how key performance indicators such as average claim costs, specialty spend, rebates, member cost share, and utilization trends can influence overall plan performance and financial outcomes.
- Recognize when benchmark results warrant further investigation – Learn how to distinguish normal market variation from performance gaps that may signal opportunities for contract optimization, procurement, or ongoing monitoring.
About the Speaker:

Kian Bichoupan, PhD, Chief Strategy Officer
Kian brings more than a decade of experience across the pharmacy and healthcare industry, spanning both pharmaceutical manufacturers and pharmacy benefit management. He specializes in procurement and service monitoring for employer plan sponsors and is also a prolific researcher, with more than 50 publications and presentations on healthcare economics, drug pricing, and real-world evidence, primarily focused on infectious diseases.